Trial Profile
NU 13H05: A Phase Ib Trial of Oncoquest-CLL Vaccine for Treatment-Naive Patients With Chronic Lymphocytic Leukemia
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Jan 2024
Price :
$35
*
At a glance
- Drugs Chronic lymphocytic leukaemia vaccine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- Sponsors XEME Biopharma
- 07 Apr 2021 Planned End Date changed from 1 Jan 2022 to 1 Jan 2024.
- 07 Apr 2021 Planned primary completion date changed from 1 Jan 2021 to 1 Jan 2024.
- 08 Jan 2019 Planned End Date changed from 1 Dec 2017 to 1 Jan 2022.